Programmed Death Ligand-1 (PD-L1) regulated by NRF- 2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.

In conclusion, our data suggested a NRF-2/miR-1/PD-L1 regulatory axis contributed to development and maintenance of drugCopyright© 2020 Cognizant Communication Corporation4ORM-A-3264 Oncology Research E-pubresistance and other tumorigenic properties in sorafenib-resistant hepatoma cells andprovided a potential therapeutic target for overcoming sorafenib resistance in HCC. PMID: 32560747 [PubMed - as supplied by publisher]
Source: Oncology Research - Category: Cancer & Oncology Tags: Oncol Res Source Type: research